Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

The Effect of Ginseng Supplementation on Lipid Profile: GRADE-assessed Systematic Review and Dose-response Meta-analysis of Randomized Controlled Trials

Author(s): Seyyed Mostafa Arabi, Mostafa Shahraki-Jazinaki, Maryam Nayyer Abadi, Leila Sadat Bahrami, Mahla Chambari, Hossein Bahari and Amirhossein Sahebkar*

Volume 30, Issue 26, 2024

Published on: 14 June, 2024

Page: [2047 - 2058] Pages: 12

DOI: 10.2174/0113816128306300240522074056

Price: $65

Abstract

Background: This systematic review and meta-analysis aimed to evaluate the overall impact of Panax ginseng on lipid profile by synthesizing existing evidence. Cardiovascular Disease (CVD) is the leading cause of morbidity and mortality among the elderly population, and serum lipids play a crucial role in its development. Maintaining optimal levels of triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and total cholesterol is essential in reducing the risk of CVD. Ginsenosides, the active constituents in ginseng, have shown positive effects on lipid metabolism. This review aimed to provide a comprehensive understanding of the potential benefits of ginseng in managing dyslipidemia, which could have significant implications for the prevention and treatment of CVD.

Methods: A comprehensive analysis of 29 Randomized Controlled Trials (RCTs) was conducted to assess the effects of ginseng supplementation on lipid profile, including Triglyceride (TG), Total Cholesterol (TC), High-density Lipoprotein Cholesterol (HDL-C), and Low-density Lipoprotein Cholesterol (LDL-C) levels. A systematic search was done in online databases, such as MEDLINE, Scopus, and Clarivate Analytics Web of Science, using relevant keywords and MeSH terms to identify relevant studies until January 2024.

Results: The Weighted Mean Differences (WMD) and 95% Confidence Intervals (CI) for TG, TC, LDL-C, and HDL-C did not show significant changes with ginseng supplementation.

Conclusion: Taking into account the results, using ginseng did not have a statistically significant influence on lipid profile parameters in individuals with different health conditions. Further, well-designed RCTs focusing on specific diseases are needed to clarify the potential beneficial effects of ginseng and its derivatives on lipid profile.

« Previous Next »
[1]
Buizert PJ, van Schoor NM, Lips P, Deeg DJH, Eekhoff EM. Lipid levels: A link between cardiovascular disease and osteoporosis? J Bone Miner Res 2009; 24(6): 1103-9.
[http://dx.doi.org/10.1359/jbmr.081262] [PMID: 19113906]
[2]
Gadó K, Szabo A, Markovics D, Virág A. Most common cardiovascular diseases of the elderly: A review article. Develop Heal Sci 2022; 4(2): 27-32.
[http://dx.doi.org/10.1556/2066.2021.00048]
[3]
Lee Y, Siddiqui WJ. Cholesterol levels. Treasure Island (FL): StatPearls Publishing 2019.
[4]
You A. Scientific report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Departments of Agriculture and Health and Human Services, 2015. Adv Nutr 2015; 7(1): 202-4.
[5]
Garber AJ, Handelsman Y, Grunberger G, et al. Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm–2020 executive summary. Endocr Pract 2020; 26(1): 107-39.
[http://dx.doi.org/10.4158/CS-2019-0472] [PMID: 32022600]
[6]
Chiavaroli L, Viguiliouk E, Nishi S, et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients 2019; 11(2): 338.
[http://dx.doi.org/10.3390/nu11020338] [PMID: 30764511]
[7]
Du K, Fan Y, Li D. Sulforaphane ameliorates lipid profile in rodents: An updated systematic review and meta-analysis. Sci Rep 2021; 11(1): 7804.
[http://dx.doi.org/10.1038/s41598-021-87367-9] [PMID: 33833347]
[8]
Tackett KL, Jones MC. Complementary and alternative medicines for the treatment of diabetes. J Pharm Pract 2009; 22(6): 546-52.
[http://dx.doi.org/10.1177/0897190009332658]
[9]
Phutrakool P, Pongpirul K. Acceptance and use of complementary and alternative medicine among medical specialists: A 15-year systematic review and data synthesis. Syst Rev 2022; 11(1): 10.
[http://dx.doi.org/10.1186/s13643-021-01882-4] [PMID: 35027078]
[10]
Wang N, Huang X, Li T, et al. Application of RRLC-QTOF-MS-based metabonomics and UPE for investigating Spleen-Qi deficiency syndrome with Panax ginseng treatment. J Ethnopharmacol 2020; 256: 112822.
[http://dx.doi.org/10.1016/j.jep.2020.112822] [PMID: 32247146]
[11]
Kitts DD, Hu C. Efficacy and safety of ginseng. Public Health Nutr 2000; 3(4a): 473-85.
[http://dx.doi.org/10.1017/S1368980000000550] [PMID: 11276295]
[12]
Jia L, Zhao Y, Liang X. Curr Med Chem: Current evaluation of the millennium phytomedicine-ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine. Altern Med Rev 2009; 14(4): 411-2.
[13]
Kim JH, Yi YS, Kim MY, Cho JY. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J Ginseng Res 2017; 41(4): 435-43.
[http://dx.doi.org/10.1016/j.jgr.2016.08.004] [PMID: 29021688]
[14]
Mittler R. Oxidative stress, antioxidants and stress tolerance. Trends Plant Sci 2002; 7(9): 405-10.
[http://dx.doi.org/10.1016/S1360-1385(02)02312-9] [PMID: 12234732]
[15]
Kim S, Park K-S. Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol Res 2003; 48(5): 511-3.
[http://dx.doi.org/10.1016/S1043-6618(03)00189-0] [PMID: 12967598]
[16]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 2009; 151(4): 264-269, W64.
[http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135] [PMID: 19622511]
[17]
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions, version 50 2. The Cochrane Collaboration, 2009. 2010.
[18]
Rahnama I, Arabi SM, Chambari M, et al. The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials. Pharmacol Res 2023; 193: 106802.
[http://dx.doi.org/10.1016/j.phrs.2023.106802] [PMID: 37263369]
[19]
Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: A new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Libr 2019; 10(10): ED000142.
[http://dx.doi.org/10.1002/14651858.ED000142] [PMID: 31643080]
[20]
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta- analysis. Stat Med 2002; 21(11): 1539-58.
[http://dx.doi.org/10.1002/sim.1186] [PMID: 12111919]
[21]
Crippa A, Orsini N. Dose-response meta-analysis of differences in means. BMC Med Res Methodol 2016; 16(1): 91.
[http://dx.doi.org/10.1186/s12874-016-0189-0] [PMID: 27485429]
[22]
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-34.
[http://dx.doi.org/10.1136/bmj.315.7109.629] [PMID: 9310563]
[23]
de Andrade E, de Mesquita AA, de Almeida Claro J, et al. Study of the efficacy of Korean red ginseng in the treatment of erectile dysfunction. Asian J Androl 2007; 9(2): 241-4.
[http://dx.doi.org/10.1111/j.1745-7262.2007.00210.x] [PMID: 16855773]
[24]
Shin K-S, Lee J-J, Kim Y-I, Yu J-Y, Park E-S. Effect of Korean red ginseng extract on blood circulation in healthy volunteers: A randomized, double-blind, placebo-controlled trial. J Ginseng Res 2007; 31(2): 109-16.
[http://dx.doi.org/10.5142/JGR.2007.31.2.109]
[25]
Duan L, Liu Y, Li J, et al. Panax notoginseng saponins alleviate coronary artery disease through hypermethylation of the miR-194-MAPK pathway. Front Pharmacol 2022; 13: 829416.
[http://dx.doi.org/10.3389/fphar.2022.829416] [PMID: 35784716]
[26]
Chung IM, Lim JW, Pyun WB, Kim HY. Korean red ginseng improves vascular stiffness in patients with coronary artery disease. J Ginseng Res 2010; 34(3): 212-8.
[http://dx.doi.org/10.5142/jgr.2010.34.3.212]
[27]
Shin SK, Kwon JH, Jeong YJ, Jeon SM, Choi JY, Choi MS. Supplementation of cheonggukjang and red ginseng cheonggukjang can improve plasma lipid profile and fasting blood glucose concentration in subjects with impaired fasting glucose. J Med Food 2011; 14(1-2): 108-13.
[http://dx.doi.org/10.1089/jmf.2009.1366] [PMID: 21128827]
[28]
Kim HO, Park MJ, Han JS. Effects of fermented red ginseng supplementation on blood glucose and insulin resistance in type 2 diabetic patients. J Kor Soc Food Sci Nutr 2011; 40(5): 696-703.
[http://dx.doi.org/10.3746/jkfn.2011.40.5.696]
[29]
Ahn CM, Hong SJ, Choi SC, Park JH, Kim JS, Lim DS. Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother Res 2011; 25(2): 239-49.
[http://dx.doi.org/10.1002/ptr.3250] [PMID: 20641058]
[30]
Rhee MY, Kim YS, Bae JH, et al. Effect of Korean red ginseng on arterial stiffness in subjects with hypertension. J Altern Complement Med 2011; 17(1): 45-9.
[http://dx.doi.org/10.1089/acm.2010.0065] [PMID: 21235416]
[31]
Kim SY, Seo SK, Choi YM, et al. Effects of red ginseng supplementation on menopausal symptoms and cardiovascular risk factors in postmenopausal women. Menopause 2012; 19(4): 461-6.
[http://dx.doi.org/10.1097/gme.0b013e3182325e4b] [PMID: 22027944]
[32]
Lee NH, Yoo SR, Kim HG, Cho JH, Son CG. Safety and tolerability of Panax ginseng root extract: A randomized, placebo-controlled, clinical trial in healthy Korean volunteers. J Altern Complement Med 2012; 18(11): 1061-9.
[http://dx.doi.org/10.1089/acm.2011.0591] [PMID: 22909282]
[33]
Yoon JW, Kang SM, Vassy JL, et al. Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study. J Diabetes Investig 2012; 3(3): 309-17.
[http://dx.doi.org/10.1111/j.2040-1124.2011.00185.x] [PMID: 24843582]
[34]
Park BJ, Lee YJ, Lee HR, et al. Effects of Korean red ginseng on cardiovascular risks in subjects with metabolic syndrome: A double-blind randomized controlled study. Korean J Fam Med 2012; 33(4): 190-6.
[http://dx.doi.org/10.4082/kjfm.2012.33.4.190] [PMID: 22916320]
[35]
Kwon DH, Bose S, Song MY, et al. Efficacy of Korean red ginseng by single nucleotide polymorphism in obese women: Randomized, double-blind, placebo-controlled trial. J Ginseng Res 2012; 36(2): 176-89.
[http://dx.doi.org/10.5142/jgr.2012.36.2.176] [PMID: 23717118]
[36]
Cho YH, Ahn SC, Lee SY, et al. Effect of Korean red ginseng on insulin sensitivity in non-diabetic healthy overweight and obese adults. Asia Pac J Clin Nutr 2013; 22(3): 365-71.
[PMID: 23945406]
[37]
Oh MR, Park SH, Kim SY, et al. Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: A randomized, double-blind, placebo- controlled clinical trial. BMC Complement Altern Med 2014; 14(1): 237.
[http://dx.doi.org/10.1186/1472-6882-14-237] [PMID: 25015735]
[38]
Bang H, Kwak JH, Ahn HY, Shin DY, Lee JH. Korean red ginseng improves glucose control in subjects with impaired fasting glucose, impaired glucose tolerance, or newly diagnosed type 2 diabetes mellitus. J Med Food 2014; 17(1): 128-34.
[http://dx.doi.org/10.1089/jmf.2013.2889] [PMID: 24456363]
[39]
Jung DH, Lee YJ, Kim CB, Kim JY, Shin SH, Park JK. Effects of ginseng on peripheral blood mitochondrial DNA copy number and hormones in men with metabolic syndrome: A randomized clinical and pilot study. Complement Ther Med 2016; 24: 40-6.
[http://dx.doi.org/10.1016/j.ctim.2015.12.001] [PMID: 26860800]
[40]
Park SY, Shin YK, Kim HT, et al. A single-center, randomized, double-blind, placebo-controlled study on the efficacy and safety of “enzyme-treated red ginseng powder complex (BG11001)” for antiwrinkle and proelasticity in individuals with healthy skin. J Ginseng Res 2016; 40(3): 260-8.
[http://dx.doi.org/10.1016/j.jgr.2015.08.006] [PMID: 27616902]
[41]
Hong M, Lee YH, Kim S, et al. Anti-inflammatory and antifatigue effect of Korean red ginseng in patients with nonalcoholic fatty liver disease. J Ginseng Res 2016; 40(3): 203-10.
[http://dx.doi.org/10.1016/j.jgr.2015.07.006] [PMID: 27616896]
[42]
Choi HS, Kim S, Kim MJ, et al. Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial. J Ginseng Res 2018; 42(1): 90-7.
[http://dx.doi.org/10.1016/j.jgr.2017.01.003] [PMID: 29348727]
[43]
Baek JH, Heo JY, Fava M, et al. Effect of Korean red ginseng in individuals exposed to high stress levels: A 6-week, double-blind, randomized, placebo-controlled trial. J Ginseng Res 2019; 43(3): 402-7.
[http://dx.doi.org/10.1016/j.jgr.2018.03.001] [PMID: 31308812]
[44]
Jung SJ, Hwang JH, Park SH, et al. A 12-week, randomized, double-blind study to evaluate the efficacy and safety of liver function after using fermented ginseng powder (GBCK25). Food Nutr Res 2020; 64: 64.
[http://dx.doi.org/10.29219/fnr.v64.3517] [PMID: 32425736]
[45]
Hwang JH, Park SH, Choi EK, Jung SJ, Pyo MK, Chae SW. A randomized, double-blind, placebo-controlled pilot study to assess the effects of protopanaxadiol saponin–enriched ginseng extract and pectinase-processed ginseng extract on the prevention of acute respiratory illness in healthy people. J Ginseng Res 2020; 44(5): 697-703.
[http://dx.doi.org/10.1016/j.jgr.2019.01.002] [PMID: 32913399]
[46]
Seong E, Bose S, Han SY, et al. Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial. EPMA J 2021; 12(2): 177-97.
[http://dx.doi.org/10.1007/s13167-021-00243-4] [PMID: 34194584]
[47]
Chung TH, Kim JH, Seol SY, Kim YJ, Lee YJ. The effects of Korean red ginseng on biological aging and antioxidant capacity in postmenopausal women: A double-blind randomized controlled study. Nutrients 2021; 13(9): 3090.
[http://dx.doi.org/10.3390/nu13093090] [PMID: 34578969]
[48]
Mahdy Hassanzadeh D, Hedayatollah F, Morteza M, et al. The effects of Panax ginseng on lipid profile, pro-oxidant: Antioxidant status and high-sensitivity C reactive protein levels in hyperlipidemic patients in Iran. Int J Prev Med 2013; 4(9): 1045-51.
[49]
Hosseini SA, Ehsanpour A, Asgari M, Malihi R. Evaluation of standardized ginseng extract Panax (G115®) effect on fasting blood glucose levels, glycated hemoglobin and lipid profile in patients with diabetes type 2. Jundishapur J Chron Dis Care 2013; 2(3): e93793.
[50]
Vuksan V, Xu ZZ, Jovanovski E, et al. Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: A double-blind, randomized, cross-over clinical trial. Eur J Nutr 2019; 58(3): 1237-45.
[http://dx.doi.org/10.1007/s00394-018-1642-0] [PMID: 29478187]
[51]
Jovanovski E, Smircic-Duvnjak L, Komishon A, et al. Effect of coadministration of enriched Korean red ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A randomized controlled trial. J Ginseng Res 2021; 45(5): 546-54.
[http://dx.doi.org/10.1016/j.jgr.2019.11.005] [PMID: 34803424]
[52]
Ziaei R, Ghavami A, Ghaedi E, Hadi A, Javadian P, Clark CCT. The efficacy of ginseng supplementation on plasma lipid concentration in adults: A systematic review and meta-analysis. Complement Ther Med 2020; 48: 102239.
[http://dx.doi.org/10.1016/j.ctim.2019.102239] [PMID: 31987252]
[53]
Naseri K, Saadati S, Sadeghi A, et al. The efficacy of ginseng (Panax) on human prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis. Nutrients 2022; 14(12): 2401.
[http://dx.doi.org/10.3390/nu14122401] [PMID: 35745129]
[54]
Park SH, Chung S, Chung MY, Choi HK, Hwang JT, Park JH. Effects of Panax ginseng on hyperglycemia, hypertension, and hyperlipidemia: A systematic review and meta-analysis. J Ginseng Res 2022; 46(2): 188-205.
[http://dx.doi.org/10.1016/j.jgr.2021.10.002] [PMID: 35509826]
[55]
Goldenberg JZ, Day A, Brinkworth GD, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: Systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021; 372: m4743.
[http://dx.doi.org/10.1136/bmj.m4743]
[56]
Lee SeoHyun LS, Lee MakSoon LM, Kim ChongTai KC. Ginsenoside Rg3 reduces lipid accumulation with AMP-activated protein kinase (AMPK) activation in HepG2 cells. Int J Mol Sci 2012; 13(5): 5729-39.
[57]
Chong SKF, Oberholzer VG. Ginseng is there a use in clinical medicine? Postgrad Med J 1988; 64(757): 841-6.
[http://dx.doi.org/10.1136/pgmj.64.757.841] [PMID: 3076665]
[58]
Lee YM, Yoon H, Park HM, Song BC, Yeum KJ. Implications of red Panax ginseng in oxidative stress associated chronic diseases. J Ginseng Res 2017; 41(2): 113-9.
[http://dx.doi.org/10.1016/j.jgr.2016.03.003] [PMID: 28413314]
[59]
Wang HY, Qi LW, Wang CZ, Li P. Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides. Am J Chin Med 2011; 39(6): 1103-15.
[http://dx.doi.org/10.1142/S0192415X11009433] [PMID: 22083984]
[60]
Lee YS, Chung IS, Lee IR, Kim KH, Hong WS, Yun YS. Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res 1997; 17(1A): 323-31.
[PMID: 9066672]
[61]
Kim KH, Lee YS, Jung IS, et al. Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med 1998; 64(2): 110-5.
[http://dx.doi.org/10.1055/s-2006-957385] [PMID: 9525101]
[62]
Jin W, Li C, Yang S, et al. Hypolipidemic effect and molecular mechanism of ginsenosides: A review based on oxidative stress. Front Pharmacol 2023; 14: 1166898.
[http://dx.doi.org/10.3389/fphar.2023.1166898] [PMID: 37188264]
[63]
Gao Y, Zhang S, Li J, et al. Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid. Biosci Biotechnol Biochem 2020; 84(11): 2228-40.
[http://dx.doi.org/10.1080/09168451.2020.1793293] [PMID: 32654591]
[64]
Shen L, Xiong Y, Wang DQH, et al. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res 2013; 54(5): 1430-8.
[http://dx.doi.org/10.1194/jlr.M035907] [PMID: 23434611]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy